Mutual Advisors, LLC Novartis Ag Transaction History

Mutual Advisors, LLC

  • $4.2 Billion
  • Q3 2025

A detailed history of Mutual Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Mutual Advisors, LLC holds 3,968 shares of NVS stock, worth $521,990. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,968
Previous 3,874 2.43%
Holding current value
$521,990
Previous $468,000 8.55%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025
BUY
$113.5 - $129.73 $10,669 - $12,194
94 Added 2.43%
3,968 $508,000
Q2 2025

Jul 28, 2025
SELL
$101.96 - $121.01 $512,756 - $608,559
-5,029 Reduced 56.49%
3,874 $468,000
Q1 2025

Apr 28, 2025
BUY
$97.14 - $115.57 $1,359 - $1,617
14 Added 0.16%
8,903 $992,000
Q4 2024

Jan 17, 2025
BUY
$96.78 - $117.18 $6,000 - $7,265
62 Added 0.7%
8,889 $864,000
Q3 2024

Oct 25, 2024
SELL
$106.13 - $120.89 $206,422 - $235,131
-1,945 Reduced 18.06%
8,827 $1.02 Million
Q2 2024

Jul 30, 2024
SELL
$92.57 - $107.37 $6,665 - $7,730
-72 Reduced 0.66%
10,772 $1.15 Million
Q1 2024

May 02, 2024
BUY
$95.27 - $108.47 $159,291 - $181,361
1,672 Added 18.23%
10,844 $1.05 Million
Q4 2023

Jan 12, 2024
SELL
$92.27 - $101.54 $193,951 - $213,437
-2,102 Reduced 18.64%
9,172 $926,000
Q3 2023

Nov 13, 2023
SELL
$94.73 - $105.13 $113,391 - $125,840
-1,197 Reduced 9.6%
11,274 $1.15 Million
Q2 2023

Jul 31, 2023
BUY
$92.52 - $104.91 $299,024 - $339,069
3,232 Added 34.98%
12,471 $1.26 Million
Q1 2023

Apr 11, 2023
SELL
$80.03 - $92.81 $22,648 - $26,265
-283 Reduced 2.97%
9,239 $849,000
Q4 2022

Jan 12, 2023
BUY
$75.55 - $92.52 $5,212 - $6,383
69 Added 0.73%
9,522 $0
Q3 2022

Nov 03, 2022
SELL
$74.61 - $87.26 $133,402 - $156,020
-1,788 Reduced 15.91%
9,453 $719,000
Q2 2022

Aug 15, 2022
SELL
$80.52 - $93.75 $14,735 - $17,156
-183 Reduced 1.6%
11,241 $950,000
Q1 2022

May 09, 2022
SELL
$80.11 - $90.62 $47,745 - $54,009
-596 Reduced 4.96%
11,424 $1 Million
Q4 2021

Feb 14, 2022
BUY
$79.7 - $88.13 $40,407 - $44,681
507 Added 4.4%
12,020 $1.05 Million
Q3 2021

Nov 15, 2021
BUY
$81.78 - $95.14 $52,666 - $61,270
644 Added 5.93%
11,513 $942,000
Q2 2021

Aug 12, 2021
BUY
$85.24 - $94.15 $58,645 - $64,775
688 Added 6.76%
10,869 $992,000
Q1 2021

May 13, 2021
SELL
$83.5 - $98.47 $81,078 - $95,614
-971 Reduced 8.71%
10,181 $870,000
Q4 2020

Feb 11, 2021
SELL
$78.07 - $94.43 $49,496 - $59,868
-634 Reduced 5.38%
11,152 $1.05 Million
Q3 2020

Nov 13, 2020
SELL
$82.14 - $91.0 $14,538 - $16,107
-177 Reduced 1.48%
11,786 $1.03 Million
Q2 2020

Aug 05, 2020
BUY
$80.93 - $91.1 $5,907 - $6,650
73 Added 0.61%
11,963 $1.05 Million
Q1 2020

May 13, 2020
SELL
$70.67 - $99.01 $12,084 - $16,930
-171 Reduced 1.42%
11,890 $980,000
Q4 2019

Feb 11, 2020
BUY
$84.35 - $95.37 $23,196 - $26,226
275 Added 2.33%
12,061 $1.14 Million
Q3 2019

Nov 01, 2019
SELL
$85.54 - $94.26 $16,765 - $18,474
-196 Reduced 1.64%
11,786 $1.02 Million
Q2 2019

Aug 15, 2019
BUY
$75.4 - $92.8 $52,855 - $65,052
701 Added 6.21%
11,982 $1.09 Million
Q1 2019

May 15, 2019
BUY
$75.32 - $86.15 $16,344 - $18,694
217 Added 1.96%
11,281 $1.09 Million
Q4 2018

Feb 15, 2019
SELL
$73.66 - $82.02 $28,138 - $31,331
-382 Reduced 3.34%
11,064 $949,000
Q3 2018

Nov 15, 2018
BUY
$66.94 - $77.43 $197,473 - $228,418
2,950 Added 34.72%
11,446 $986,000
Q2 2018

Aug 15, 2018
BUY
$64.91 - $73.36 $19,148 - $21,641
295 Added 3.6%
8,496 $642,000
Q1 2018

May 11, 2018
BUY
$70.39 - $84.15 $54,974 - $65,721
781 Added 10.53%
8,201 $663,000
Q4 2017

Feb 12, 2018
BUY
$72.33 - $77.64 $536,688 - $576,088
7,420
7,420 $623,000

Others Institutions Holding NVS

# of Institutions
1,601
Shares Held
137M
Call Options Held
1.53M
Put Options Held
2.22M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Mutual Advisors, LLC Portfolio

Follow Mutual Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email